Physician profile
Frederick Beavers
NPI 1740287606
$4,869.34
in general payments reported to CMS, 2019-2025
9 companies · $53.46 in 2025
The $53.46 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,628 · 2020: $85.80 · 2022: $40.67 · 2023: $46.37 · 2024: $14.82 · 2025: $53.46.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $115.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $114.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Molnlycke Health Care US, LLC | $4,118.26 | 2019 | |
| Cook Incorporated | $509.96 | 2019 | |
| Silk Road Medical, INC. | $67.12 | 2020 | |
| Cashflow Solutions, LLC | $50.49 | 2023-2025 | Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White, Pcd-51 731a (US) - White |
| Stryker Corporation | $35.86 | 2025 | Artix Mt |
| Tactile Systems Technology INC | $28.30 | 2023-2024 | Flexitouch Plus, Entre Plus |
| Lemaitre Vascular, INC. | $21.20 | 2022 | |
| Organogenesis INC. | $19.47 | 2022 | |
| Cook Medical LLC | $18.68 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frederick Beavers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.